logo
  

ImmixBio: IMX-110 Shows Improved Survival In Connective Tissue Cancer Soft Tissue Sarcoma Mice Study

Immix Biopharma Inc. (IMMX) announced positive interim study data showing that after one cycle of treatment, ImmixBio's lead candidate IMX-110 produced 75% survival vs. 0% survival for Trabectedin in a connective tissue cancer Soft Tissue Sarcoma or STS mice study.

Trabectedin is sold as YONDELIS by Janssen, a Johnson & Johnson Company, a U.S. FDA approved drug.

In the study, IMX-110 was compared against approved drugs used to treat STS. Trabectedin was dosed according to Meco et. al., 2003 (trabectedin monotherapy treatment arm) and IMX-110 was administered at 2.0 mg/kg.

In Friday pre-market trade, IMMX was trading at $2.50 up $0.87 or 53.37%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores. The U.S. Food and Drug Administration has authorized state-licensed pharmacists to prescribe COVID-19 pill Paxlovid (nirmatrelvir and ritonavir) by drug major Pfizer Inc. to eligible patients, with certain limitations. The agency has revised the Emergency Use Authorization or EUA for Paxlovid for the authorization, which could improve access for some patients at high risk for severe covid-19. Retail major Walmart's popular InHome direct-to-fridge delivery service is now available as an optional add-on within its membership plan Walmart+. Walmart also launched InHome service, which delivers groceries straight to one's fridge, in several new markets including Miami, Tampa, Orlando, Dallas, Austin, San Jose and San Francisco.
Follow RTT